TB

This document contains an overview of what TB Care I is doing to help with the fight against childhood TB.

This document contains links to over 650 tools and reference materials. It is intended for national TB program staff in high burden settings who are trying to identify strategies to reach at-risk and vulnerable communities more effectively. The goal of the document is to introduce readers to the range of tools and strategies that are available in TB control.

This set of 11 training modules on the Xpert MTB/RIF assay was developed by Global Laboratory Initiative partners, including FIND, KNCV, USAID, CDC and WHO. The modules include topics such as biosafety, specimen collection and transportation, supplies management, installation, Xpert MTB/RIF procedures, recording and reporting, and troubleshooting.

This guide provides a summary of safety and efficacy data for drugs currently in use to treat TB. The guide also suggests advocacy points for activists, clinicians, and others working in TB.

This guide was developed by the Global Laboratory Initiative, which is one of the Working Groups of the Stop TB Partnership. The guide replaces both the 1998 WHO and 2000 IUATLD guides on smear microscopy and contains many new elements.

This online course explains how the FAST strategy can be applied in various settings. FAST stands for: Finding TB cases, Actively, Separating safely, and Treating effectively.

This online course discusses critical principles and steps to facilitate treatment adherence for MDR-TB patients. The five A’s are: Assess, Advise, Agree, Arrange, and Assist.

This poster encourages people to buy queso fresco from safe sources. It was developed for and tested with low-literacy Spanish-speaking populations.

This pocket guide is intended to be a resource for physicians and other health care professionals who provide care and treatment to patients with MDR TB. The guide is a revision of The PIH Guide to the Medical Management of MDR-TB that was published in 2003.

This laboratory manual references best practices from the Clinical and Laboratory Standards Institute (CLSI), the Foundation for Innovative New Diagnostics (FIND) MGIT Procedure Manual, and laboratory procedures from the National Institutes of Health TB Research Unit, as well as biosafety recommendations from the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC).

Information in the manual includes standardized procedures related to sputum collection, handling, analyses, and reporting.